These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10951143)

  • 1. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
    Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
    Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
    J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.
    Shirakata Y; Amagai M; Hanakawa Y; Nishikawa T; Hashimoto K
    J Invest Dermatol; 1998 Jan; 110(1):76-8. PubMed ID: 9424092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin autoantibody profile in patients with pemphigus vulgaris.
    Oliveira ME; Culton DA; Prisayanh P; Qaqish BF; Diaz LA
    Br J Dermatol; 2013 Oct; 169(4):812-8. PubMed ID: 23725016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
    Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
    Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules.
    Ohyama B; Nishifuji K; Chan PT; Kawaguchi A; Yamashita T; Ishii N; Hamada T; Dainichi T; Koga H; Tsuruta D; Amagai M; Hashimoto T
    J Invest Dermatol; 2012 Apr; 132(4):1158-68. PubMed ID: 22277941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.